Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Doris Zimmermann
The Use of an Oral Contraceptive Containing Ethinylestradiol and Drospirenone in an Extended Regimen Over 126 Days
Contraception
Gynecology
Reproductive Medicine
Obstetrics
Related publications
Efficacy and Tolerability of a Monophasic Combined Oral Contraceptive Containing Nomegestrol Acetate and 17β-Oestradiol in a 24/4 Regimen, in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Drospirenone in a 21/7 Regimen
European Journal of Contraception and Reproductive Health Care
Medicine
Gynecology
Reproductive Medicine
Pharmacology
Obstetrics
Contraceptive Efficacy and Tolerability of Ethinylestradiol 20 Μg/Drospirenone 3 Mg in a Flexible Extended Regimen: An Open-Label, Multicentre, Randomised, Controlled Study
Journal of Family Planning and Reproductive Health Care
Yasminelle®: A New Low-Dose Combined Oral Contraceptive Containing Drospirenone
Women's Health
Medicine
Drospirenone-Containing Oral Contraceptives and Venous Thromboembolism: An Analysis of the FAERS Database
Open Access Journal of Contraception
Is It Ethical to Use Drospirenone-Containing Combined Oral Contraceptives?
Journal of Family Planning and Reproductive Health Care
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: A Systematic Review of Observational Studies
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
Effects of a New Oral Contraceptive Containing an Antimineralocorticoid Progestogen, Drospirenone, on the Renin-Aldosterone System, Body Weight, Blood Pressure, Glucose Tolerance, and Lipid Metabolism.
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Is It Ethical to Use Drospirenone-Containing Combined Oral Contraceptives?: Authors' Response
Journal of Family Planning and Reproductive Health Care
A Combined Oral Contraceptive Containing 30 MCG Ethinyl Estradiol and 3.0 Mg Drospirenone Does Not Impair Endothelium-Dependent Vasodilation
Contraception
Gynecology
Reproductive Medicine
Obstetrics